Effect of endothelium-specific insulin resistance on endothelial function in vivo.
about
Nitric oxide, oxidative stress, and p66Shc interplay in diabetic endothelial dysfunctionPreserved Microvascular Endothelial Function in Young, Obese Adults with Functional Loss of Nitric Oxide Signaling.The insulin-like growth factor-1 receptor is a negative regulator of nitric oxide bioavailability and insulin sensitivity in the endotheliumProkineticin Is a New Linker between Obesity and Cardiovascular DiseasesRegulation of obesity and insulin resistance by nitric oxideThe novel ATP-sensitive potassium channel opener iptakalim prevents insulin resistance associated with hypertension via restoring endothelial function.Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms.Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications.Vascular dysfunction associated with type 2 diabetes and Alzheimer's disease: a potential etiological linkage.Sinusoidal endothelial dysfunction precedes inflammation and fibrosis in a model of NAFLD.Metabolomic analyses for atherosclerosis, diabetes, and obesity.Loss of insulin signaling in vascular endothelial cells accelerates atherosclerosis in apolipoprotein E null miceAdipocyte heme oxygenase-1 induction attenuates metabolic syndrome in both male and female obese mice.Insulin resistance impairs circulating angiogenic progenitor cell function and delays endothelial regenerationAntiobesogenic role of endothelial nitric oxide synthase.Forkhead box O-1 modulation improves endothelial insulin resistance in human obesity.Visceral adiposopathy: a vascular perspectiveEpoxyeicosatrienoic acids and heme oxygenase-1 interaction attenuates diabetes and metabolic syndrome complicationsIncreasing circulating IGFBP1 levels improves insulin sensitivity, promotes nitric oxide production, lowers blood pressure, and protects against atherosclerosisFoxOs integrate pleiotropic actions of insulin in vascular endothelium to protect mice from atherosclerosis.Insulin resistance, metabolic stress, and atherosclerosis.Novel role of the IGF-1 receptor in endothelial function and repair: studies in endothelium-targeted IGF-1 receptor transgenic mice."Non alcoholic fatty liver disease and eNOS dysfunction in humans"Microvascular management of systemic insulin sensitivity.Mineralocorticoid receptor-mediated vascular insulin resistance: an early contributor to diabetes-related vascular disease?Role of insulin resistance in endothelial dysfunction.Glycemic associations with endothelial function and biomarkers among 5 ethnic groups: the Multi-Ethnic Study of Atherosclerosis and the Mediators of Atherosclerosis in South Asians Living in America studiesSIRT3 Deficiency Induces Endothelial Insulin Resistance and Blunts Endothelial-Dependent Vasorelaxation in Mice and Human with Obesity.Changing the way we think about endothelial cell insulin sensitivity, nitric oxide, and the pathophysiology of type 2 diabetes: the FoxO is loose.Additive Effect of Non-Alcoholic Fatty Liver Disease on Metabolic Syndrome-Related Endothelial Dysfunction in Hypertensive Patients.Diurnal variation in vascular and metabolic function in diet-induced obesity: divergence of insulin resistance and loss of clock rhythm.Opportunity "nox": a novel approach to preventing endothelial dysfunction in the context of insulin resistance.Nox2 NADPH oxidase has a critical role in insulin resistance-related endothelial cell dysfunction.Molecular Basis of Insulin Resistance: The Role of IRS and Foxo1 in the Control of Diabetes Mellitus and Its ComplicationsThe L-4F mimetic peptide prevents insulin resistance through increased levels of HO-1, pAMPK, and pAKT in obese miceProkineticin receptor-1 is a new regulator of endothelial insulin uptake and capillary formation to control insulin sensitivity and cardiovascular and kidney functions.Vascular actions of insulin with implications for endothelial dysfunction.New insights into insulin action and resistance in the vasculature.The role of IGF-1 resistance in obesity and type 2 diabetes-mellitus-related insulin resistance and vascular disease.The link between metabolic abnormalities and endothelial dysfunction in type 2 diabetes: an update.
P2860
P921
Q26830607-4596AF91-3804-4494-B6FE-57BF7B54562EQ27307929-F5C3C344-54EE-4312-A4EC-FCAE40E5741CQ28508627-370EB113-2E3C-4D4B-86D5-B55408879DCBQ30234642-6305C5F3-64A4-4440-9FBC-FAC11AA1075EQ30363035-93FE05C4-7A0E-4711-8EEE-B091A74A2C4EQ33566754-DE7D5DBA-9541-45DC-8986-322E83B6B85EQ33865096-6E2D18D3-F0B0-4CC3-AAE6-A95E70903D96Q33901576-5A7D4B11-AC62-4C3B-B239-7809F60D2E99Q34066200-89BCBC98-D2E0-48BC-9A1B-7F58B1673550Q34234946-52F70A1E-5A9F-4D31-8777-430CAF5EEBE8Q34256164-B7FADE55-7304-4932-90F3-6D4C032DA0E8Q34485920-F57FA9E2-7197-44EA-A2DB-4C74DEA9CC8FQ34540378-C24B5EFE-3D8D-4A21-B3CE-80F2C5EE2C6CQ34718887-8C760C9E-5471-4978-A628-46A3CE1538ECQ35540257-AEE0CBA5-3505-4310-98FB-6C13A1B2D3C6Q35613380-F6DC2DD6-D5CA-41EF-9658-9447E67E4B0EQ35642563-4B9DD12B-6976-45EA-A504-2DB53D43266BQ35681034-77D3BE21-1AB0-401D-883C-953282F0917BQ35857746-049C5880-2EF8-4191-BCFA-2E38C02167F2Q35861980-DBE8B7BB-A38D-47E5-89E8-F06E3238D268Q35871387-DA7B6C06-C03D-49CA-8288-02DDE80BC7BEQ36182530-EB3520C8-64F6-4C6A-8D54-EF1CD16F82E9Q36298719-CFB5E2DC-F281-4F67-B6E0-0070EE526E5CQ36371123-3CA300ED-4621-43D4-A41C-0BCB4FE4EC0BQ36560643-6DE1A8E0-E1DC-4E83-938F-5D5D54B5B3A2Q36674069-4E35D348-C2ED-4CE2-8D4B-A0B0AFAE946CQ36701766-360D9F84-5393-4CDB-89BF-616E6166BC3CQ36713609-94D82D81-32A4-4D02-887D-28385915D6A3Q36796121-274DEAA9-E2CF-49A3-9DD2-DDDAAACAE86AQ36846905-F9206A82-36EE-4790-8DA9-0750682D2484Q36867458-C0546BF3-C22F-4726-8B2A-C504F6F60A28Q36867547-22ED31DD-D5A3-4375-A96D-75563DB39793Q36867557-33A07D74-8CEA-480C-A45A-195903F8C524Q37149334-F972845E-902E-4C10-AFC8-66DF25A6589EQ37222394-A4B0FFB3-EE5D-477C-9072-5F53682E499DQ37328835-6A1DA814-A9D5-40FA-8C32-34364785F348Q37505788-0C409DE3-3921-41D0-B93C-B11CC50CA839Q37707789-DE100547-71EF-442C-8A79-DCCF049CF41BQ37807986-455A3949-564C-4978-82ED-C9DF140792A1Q37970585-57E35C41-A6A9-4D34-B195-6398CB4BFEF6
P2860
Effect of endothelium-specific insulin resistance on endothelial function in vivo.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Effect of endothelium-specific insulin resistance on endothelial function in vivo.
@en
Effect of endothelium-specific insulin resistance on endothelial function in vivo.
@en-gb
Effect of endothelium-specific insulin resistance on endothelial function in vivo.
@nl
type
label
Effect of endothelium-specific insulin resistance on endothelial function in vivo.
@en
Effect of endothelium-specific insulin resistance on endothelial function in vivo.
@en-gb
Effect of endothelium-specific insulin resistance on endothelial function in vivo.
@nl
prefLabel
Effect of endothelium-specific insulin resistance on endothelial function in vivo.
@en
Effect of endothelium-specific insulin resistance on endothelial function in vivo.
@en-gb
Effect of endothelium-specific insulin resistance on endothelial function in vivo.
@nl
P2093
P2860
P50
P356
P1433
P1476
Effect of endothelium-specific insulin resistance on endothelial function in vivo.
@en
P2093
Edward R Duncan
Gillian Douglas
Narayana Anilkumar
Paul A Crossey
Simon Walker
Vivienne A Ezzat
P2507
P2860
P304
P356
10.2337/DB07-1111
P407
P577
2008-10-03T00:00:00Z